Fatal familial insomnia with an unusual prion protein deposition pattern: an autopsy report with an experimental

K Sasaki1, K Doh-ura, Y Wakisaka

  • 1Department of Neuropathology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan. ksasaki@np.med.kyushu-u.ac.jp

Insights

Fatal familial insomnia (FFI) can present with varied symptoms due to potential prion strain variations. Post-mortem analysis revealed distinct neuropathological features and a transmissible agent different from classical FFI.

Area of Science:

  • Neuroscience
  • Pathology
  • Genetics

Background:

  • Fatal familial insomnia (FFI) is a rare, inherited prion disease.
  • It is characterized by progressive insomnia, autonomic dysfunction, and neurological decline.

Observation:

  • Post-mortem examination of a Japanese FFI patient revealed cerebellar ataxia progressing to insomnia, delirium, and myoclonus.
  • Histopathology showed neuronal loss in the thalamus and inferior olivary nucleus, with prion protein (PrP) deposition and spongiform changes in the cerebral and cerebellar cortex.

Findings:

  • Prion protein (PrP) deposition was type 2, consistent with FFI.
  • Transmission studies in mice revealed distinct neuropathological features, suggesting a different pathogen strain than classical FFI.
  • The patient's prion protein gene mutation was linked to FFI.

Implications:

  • This case suggests that variations in prion pathogen strains, alongside genetic factors, may contribute to the diverse clinical and pathological presentations of FFI.
  • Further research into prion strain diversity is crucial for understanding and potentially treating FFI.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...